Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleRegorafenib (BAY 73-4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity.AuthorsWilhelm, Scott M.; Dumas, Jacques; Adnane, Lila; Lynch, Mark; Carter, Christopher A.; Schütz, Gunnar; Thierauch, Karl-Heinz; Zopf, DieterPublicationInternational Journal of Cancer, 2011, Vol 129, Issue 1, p245ISSN0020-7136Publication typeArticleDOI10.1002/ijc.25864